Početna stranicaTEVA • TLV
add
Teva Pharmaceutical Industries
Preth. zaklj. cijena
6.320,00 ILA
Dnevni raspon
6.297,00 ILA - 6.380,00 ILA
Godišnji raspon
3.463,00 ILA - 7.323,00 ILA
Tržišna kapitalizacija
19,29 mlr. USD
Prosječna količina
911,76 tis.
P/E omjer
-
Prinos dividende
-
Glavno tržište vrijednosnica
TLV
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(USD) | ruj 2024.info | Godišnja promjena |
---|---|---|
Prihod | 4,33 mlr. | 12,52 % |
Operativni troškovi | 1,14 mlr. | 5,05 % |
Neto dohodak | −437,00 mil. | −733,33 % |
Neto profitabilnost | −10,09 | −663,69 % |
Zarada po dionici | 0,69 | 15,00 % |
EBITDA | 1,26 mlr. | 20,98 % |
Efektivna porezna stopa | −21,50 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(USD) | ruj 2024.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 3,32 mlr. | 47,58 % |
Ukupna imovina | 41,76 mlr. | −0,78 % |
Ukupne obveze | 35,37 mlr. | 2,31 % |
Ukupni kapital | 6,38 mlr. | — |
Dionice u optjecaju | 1,13 mlr. | — |
Cijena prema knjigovodstvenoj vrijednosti | 11,81 | — |
Povrat imovine | 6,04 % | — |
Povrat kapitala | 9,82 % | — |
Tok novca
Neto promjena novca
(USD) | ruj 2024.info | Godišnja promjena |
---|---|---|
Neto dohodak | −437,00 mil. | −733,33 % |
Gotovina od poslovanja | 693,00 mil. | 13.760,00 % |
Gotovina iz ulaganja | 268,00 mil. | 45,65 % |
Gotovina iz financiranja | — | — |
Neto promjena novca | 1,06 mlr. | 352,62 % |
Slobodan tok novca | 1,28 mlr. | 62,91 % |
Više
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 18th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
Glavni izvršni direktor
Osnovano
13. velj 1944.
Web-lokacija
Zaposlenici
37.000